Effect of Disease Activity on Organ Damage Progression in Systemic Lupus Erythematosus: University of Toronto Lupus Clinic Cohort.
Murray B UrowitzDafna D GladmanDominique IbanezJiandong SuSara MursleenAmyn SayaniJorge Alfonso Ross TerresSandra IczkovitzPublished in: The Journal of rheumatology (2020)
Patients within the higher SLEDAI-2K subgroups at study entry or receiving high doses of steroids were more likely to have organ damage progression.